DK0546389T3 - Piperidylmethylsubstituerede chromanderivater som virksomme stoffer til behandling af sygdomme i centralnervesystemet - Google Patents

Piperidylmethylsubstituerede chromanderivater som virksomme stoffer til behandling af sygdomme i centralnervesystemet

Info

Publication number
DK0546389T3
DK0546389T3 DK92120188.5T DK92120188T DK0546389T3 DK 0546389 T3 DK0546389 T3 DK 0546389T3 DK 92120188 T DK92120188 T DK 92120188T DK 0546389 T3 DK0546389 T3 DK 0546389T3
Authority
DK
Denmark
Prior art keywords
piperidylmethyl
treatment
nervous system
central nervous
chroman derivatives
Prior art date
Application number
DK92120188.5T
Other languages
English (en)
Inventor
Hans-Georg Dr Heine
Thomas Dr Glaser
Wolfgang Dr Dompert
Bodo Dr Junge
Peter-Rudolf Dr Seidel
Rudolf Dr Schohe-Loop
Jean-Marie Viktor Dr De Vry
Henning Dr Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0546389T3 publication Critical patent/DK0546389T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK92120188.5T 1991-12-09 1992-11-26 Piperidylmethylsubstituerede chromanderivater som virksomme stoffer til behandling af sygdomme i centralnervesystemet DK0546389T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140542A DE4140542A1 (de) 1991-12-09 1991-12-09 Piperdylmethyl substituierte chormanderivate

Publications (1)

Publication Number Publication Date
DK0546389T3 true DK0546389T3 (da) 1996-08-12

Family

ID=6446620

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92120188.5T DK0546389T3 (da) 1991-12-09 1992-11-26 Piperidylmethylsubstituerede chromanderivater som virksomme stoffer til behandling af sygdomme i centralnervesystemet

Country Status (22)

Country Link
US (1) US5326771A (da)
EP (1) EP0546389B1 (da)
JP (1) JP3162523B2 (da)
AT (1) ATE136896T1 (da)
AU (1) AU649901B2 (da)
CA (1) CA2084541A1 (da)
CZ (1) CZ281714B6 (da)
DE (2) DE4140542A1 (da)
DK (1) DK0546389T3 (da)
ES (1) ES2087407T3 (da)
FI (1) FI925550A (da)
GR (1) GR3019774T3 (da)
HU (2) HU9203896D0 (da)
IL (1) IL104005A0 (da)
MX (1) MX9206816A (da)
MY (1) MY130107A (da)
NO (1) NO303285B1 (da)
NZ (1) NZ245380A (da)
RU (1) RU2102392C1 (da)
SK (1) SK278557B6 (da)
TW (1) TW282468B (da)
ZA (1) ZA929497B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
EP0846683B1 (en) * 1996-12-03 2001-09-19 F. Hoffmann-La Roche Ag 4-Hydroxy-piperidine derivatives
CA2220649C (en) 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
SE9902765D0 (sv) 1999-07-21 1999-07-21 Astra Pharma Prod Novel compounds
CA2434015A1 (en) * 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic chroman compounds
CN100509794C (zh) 2001-01-16 2009-07-08 阿斯特拉曾尼卡有限公司 治疗性杂环化合物
CA2433950A1 (en) 2001-01-16 2002-07-18 Timothy Davenport Therapeutic chromone compounds
US20050014818A1 (en) * 2001-11-09 2005-01-20 Masaru Mitsuda Process for producing optically active chroman derivative and intermediate
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
US7470798B2 (en) * 2003-09-19 2008-12-30 Edison Pharmaceuticals, Inc. 7,8-bicycloalkyl-chroman derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826835A (en) * 1971-01-08 1974-07-30 Ciba Geigy Corp 8-benzofurylmethyl-1,3,8-triazaspiro(4,5)decanes as neuroleptics
US4016281A (en) * 1975-02-22 1977-04-05 Merck Patent Gesellschaft Mit Beschrankter Haftung Tetralone and indanone compounds
DE2950135A1 (de) * 1979-12-13 1981-06-19 Merck Patent Gmbh, 6100 Darmstadt Basischer aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
GB8515389D0 (en) * 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
US4957928A (en) * 1986-06-26 1990-09-18 Ciba-Geigy Corporation Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
FR2642068B1 (fr) * 1989-01-20 1991-04-12 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane

Also Published As

Publication number Publication date
FI925550A0 (fi) 1992-12-07
EP0546389A1 (de) 1993-06-16
HU9203896D0 (en) 1993-03-29
MX9206816A (es) 1993-07-01
HUT65525A (en) 1994-06-28
ES2087407T3 (es) 1996-07-16
IL104005A0 (en) 1993-05-13
ATE136896T1 (de) 1996-05-15
DE4140542A1 (de) 1993-06-17
GR3019774T3 (en) 1996-07-31
NZ245380A (en) 1994-06-27
NO924547D0 (no) 1992-11-25
TW282468B (da) 1996-08-01
US5326771A (en) 1994-07-05
SK361292A3 (en) 1997-09-10
NO303285B1 (no) 1998-06-22
CZ281714B6 (cs) 1996-12-11
AU649901B2 (en) 1994-06-02
NO924547L (no) 1993-06-10
ZA929497B (en) 1993-06-10
AU2993692A (en) 1993-06-10
DE59206036D1 (de) 1996-05-23
FI925550A (fi) 1993-06-10
CZ361292A3 (en) 1993-08-11
EP0546389B1 (de) 1996-04-17
JPH05262766A (ja) 1993-10-12
SK278557B6 (en) 1997-09-10
RU2102392C1 (ru) 1998-01-20
JP3162523B2 (ja) 2001-05-08
CA2084541A1 (en) 1993-06-10
MY130107A (en) 2007-06-29

Similar Documents

Publication Publication Date Title
DK0546388T3 (da) Azaheterocyclylmethyl-chromaner som aktive stoffer til behandling af sygdomme i centralnervesystemet
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
DK0546389T3 (da) Piperidylmethylsubstituerede chromanderivater som virksomme stoffer til behandling af sygdomme i centralnervesystemet
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
DE59310098D1 (de) Imidazolyl-substituierte Cyclohexanderivate
DE3772965D1 (de) Imidazol-derivate mit therapeutischer aktivitaet, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.